Publication:

Nanosilver as a new generation of nanoproduct in biomedical applications

Date

Date

Date
2010
Journal Article
Published version
cris.lastimport.scopus2025-07-12T03:35:35Z
cris.lastimport.wos2025-08-04T01:37:41Z
dc.contributor.institutionUniversity of Zurich
dc.date.accessioned2010-12-16T15:13:00Z
dc.date.available2010-12-16T15:13:00Z
dc.date.issued2010-11
dc.description.abstract

Nanosilver (NS), comprising silver nanoparticles, is attracting interest for a range of biomedical applications owing to its potent antibacterial activity. It has recently been demonstrated that NS has useful anti-inflammatory effects and improves wound healing, which could be exploited in developing better dressings for wounds and burns. The key to its broad-acting and potent antibacterial activity is the multifaceted mechanism by which NS acts on microbes. This is utilized in antibacterial coatings on medical devices to reduce nosocomial infection rates. Many new synthesis methods have emerged and are being evaluated for NS production for medical applications. NS toxicity is also critically discussed to reflect on potential concerns before widespread application in the medical field.

dc.identifier.doi10.1016/j.tibtech.2010.07.006
dc.identifier.issn0167-7799
dc.identifier.scopus2-s2.0-77957766556
dc.identifier.urihttps://www.zora.uzh.ch/handle/20.500.14742/54680
dc.identifier.wos000283703300006
dc.language.isoeng
dc.subject.ddc610 Medicine & health
dc.title

Nanosilver as a new generation of nanoproduct in biomedical applications

dc.typearticle
dcterms.accessRightsinfo:eu-repo/semantics/closedAccess
dcterms.bibliographicCitation.journaltitleTrends in Biotechnology
dcterms.bibliographicCitation.number11
dcterms.bibliographicCitation.originalpublishernameElsevier
dcterms.bibliographicCitation.pageend588
dcterms.bibliographicCitation.pagestart580
dcterms.bibliographicCitation.pmid20724010
dcterms.bibliographicCitation.volume28
dspace.entity.typePublicationen
uzh.contributor.affiliationUCL, UniversitatsSpital Zurich
uzh.contributor.affiliationUCL
uzh.contributor.affiliationUCL, Royal Free Hampstead NHS Trust
uzh.contributor.authorChaloupka, K
uzh.contributor.authorMalam, Y
uzh.contributor.authorSeifalian, A M
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceYes
uzh.document.availabilitycontent_undefined
uzh.eprint.datestamp2010-12-16 15:13:00
uzh.eprint.lastmod2025-08-04 01:48:43
uzh.eprint.statusChange2010-12-16 15:13:00
uzh.harvester.ethYes
uzh.harvester.nbNo
uzh.identifier.doi10.5167/uzh-36709
uzh.jdb.eprintsId29406
uzh.oastatus.unpaywallclosed
uzh.oastatus.zoraClosed
uzh.publication.citationChaloupka, K; Malam, Y; Seifalian, A M (2010). Nanosilver as a new generation of nanoproduct in biomedical applications. Trends in Biotechnology, 28(11):580-588.
uzh.publication.originalworkoriginal
uzh.publication.publishedStatusfinal
uzh.scopus.impact1300
uzh.scopus.subjectsBiotechnology
uzh.scopus.subjectsBioengineering
uzh.workflow.doajuzh.workflow.doaj.false
uzh.workflow.eprintid36709
uzh.workflow.fulltextStatusrestricted
uzh.workflow.revisions140
uzh.workflow.rightsCheckkeininfo
uzh.workflow.statusarchive
uzh.wos.impact1116
Files

Original bundle

Name:
Chaloupka_1.pdf
Size:
404.33 KB
Format:
Adobe Portable Document Format
Downloadable by admins only
Publication available in collections: